Wolverine Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Wolverine Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8	Closed	-$1K	–	1199
2015 Q4	$1K	Hold	8	–	–	﹤0.01%	1606
2015 Q3	$3K	Hold	8	–	–	﹤0.01%	1684
2015 Q2	$2K	Sell	8 -15	-65%	-$581	﹤0.01%	1751
2015 Q1	$8K	Buy	+23	New	+$791	﹤0.01%	1571
2014 Q4	–	Sell	-86	Closed	-$14K	–	2103
2014 Q3	$14K	Buy	+86	New	+$2.01K	﹤0.01%	1898
2014 Q1	–	Sell	-120	Closed	-$14K	–	2331
2013 Q4	$14K	Buy	+120	New	+$2.83K	﹤0.01%	2156
2013 Q3	–	Sell	-150	Closed	-$23K	–	2654
2013 Q2	$23K	Buy	+150	New	+$2.07K	﹤0.01%	1965

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wolverine Asset Management's ACAD Position: Q1 2021 in Review

Wolverine Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 2,244 shares — an estimated $119K sold.

Wolverine Asset Management first reported a position in ACAD in Q2 2013 and held it in 7 quarters. The position peaked at $464K in Q4 2013. 271 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

Wolverine Asset Management reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Wolverine Asset Management sold 2,244 Acadia Pharmaceuticals shares in Q1 2021, an estimated $119K.
Wolverine Asset Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Wolverine Asset Management's Acadia Pharmaceuticals position peaked at $464K in Q4 2013.
271 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on Wolverine Asset Management's 13F filing for Q1 2021, filed 13 May 2021.